• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Talnetant Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758437

Talnetant is a selective, competitive, brain-penetrant NK3 receptor antagonist with the ability to modulate mesolimbic and mesocortical dopaminergic neurotransmission More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Talnetant, Inhibitor
Full Product Name
Talnetant
Product Synonym Names
SB 223412
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
382.45
Solubility
DMSO: 100mg/mL (261.47mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Boiling Point
573.2+/-50.0 degree C (Predicted)
Formula
C25H22N2O2
SMILES
CCC(NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1
CAS Number
174636-32-9
Target & IC50
hNK-3-CHO: ic50 1.4nM (ki)
NK3

Structure of Talnetant, inhibitor

Talnetant Inhibitor – Cat# MBS5758437

Product References and Citations for Talnetant, inhibitor

Dawson L A, Cato K J, Scott C, et al. In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the treatment,of Schizophrenia[J]. Neuropsychopharmacology, 2008, 33(7):1642-1652.
Dawson L A, Cato K J, Scott C, et al. In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the treatment,of Schizophrenia[J]. Neuropsychopharmacology, 2008, 33(7):1642-1652.
Giuseppe A. M. Giardina, Luca F. Raveglia, Mario Grugni, et al. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).[J]. Journal of Medicinal Chemistry, 1999, 42(6):1053-1065.
Giuseppe A. M. Giardina,, Luca F. Raveglia, Mario Grugni, et al. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).[J]. Journal of Medicinal Chemistry, 1999, 42(6):1053-1065.

Other Notes

Small volumes of Talnetant, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Talnetant purchase

MBS5758437 is an inhibitor targeting Talnetant.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000